Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$341K Sell
8,517
-5,485
-39% -$260K ﹤0.01% 3721
2025
Q4
$630K Sell
14,002
-74,315
-84% -$3.44M ﹤0.01% 3539
2025
Q3
$3.95M Sell
88,317
-24,300
-22% -$1.16M ﹤0.01% 2601
2025
Q2
$5.41M Buy
112,617
+23,524
+26% +$1.02M ﹤0.01% 2297
2025
Q1
$3.58M Buy
89,093
+27,818
+45% +$1.17M ﹤0.01% 2549
2024
Q4
$2.81M Buy
61,275
+24,436
+66% +$1.09M ﹤0.01% 2731
2024
Q3
$1.73M Buy
36,839
+22,990
+166% +$1.05M ﹤0.01% 2986
2024
Q2
$585K Buy
+13,849
New +$607K ﹤0.01% 3366
2023
Q4
Sell
-8,093
Closed -$348K 3967
2023
Q3
$348K Buy
8,093
+602
+8% +$28.1K ﹤0.01% 3539
2023
Q2
$358K Buy
7,491
+1,714
+30% +$82.6K ﹤0.01% 3557
2023
Q1
$281K Sell
5,777
-5,453
-49% -$277K ﹤0.01% 3631
2022
Q4
$593K Buy
11,230
+5,337
+91% +$263K ﹤0.01% 3341
2022
Q3
$259K Sell
5,893
-352
-6% -$17.4K ﹤0.01% 3633
2022
Q2
$311K Buy
6,245
+1,494
+31% +$72.9K ﹤0.01% 3555
2022
Q1
$246K Sell
4,751
-3,231
-40% -$167K ﹤0.01% 3708
2021
Q4
$470K Buy
+7,982
New +$458K ﹤0.01% 3548
2021
Q3
Sell
-8,313
Closed -$426K 3939
2021
Q2
$426K Buy
8,313
+450
+6% +$23.2K ﹤0.01% 3517
2021
Q1
$405K Buy
7,863
+1,729
+28% +$95K ﹤0.01% 3479
2020
Q4
$343K Buy
6,134
+2,139
+54% +$114K ﹤0.01% 3461
2020
Q3
$222K Sell
3,995
-129,077
-97% -$6.69M ﹤0.01% 3512
2020
Q2
$6.04M Sell
133,072
-12,383
-9% -$554K ﹤0.01% 1924
2020
Q1
$6.42M Buy
145,455
+69,606
+92% +$2.72M ﹤0.01% 1728
2019
Q4
$2.72M Buy
+75,849
New +$2.82M ﹤0.01% 2580
2019
Q1
Sell
-10,884
Closed -$398K 3753
2018
Q4
$398K Sell
10,884
-24,184
-69% -$898K ﹤0.01% 3275
2018
Q3
$1.41M Buy
35,068
+482
+1% +$19.3K ﹤0.01% 2945
2018
Q2
$1.33M Sell
34,586
-2,593
-7% -$95.4K ﹤0.01% 2907
2018
Q1
$1.27M Sell
37,179
-56,133
-60% -$1.97M ﹤0.01% 2873
2017
Q4
$3.06M Sell
93,312
-22,738
-20% -$784K ﹤0.01% 2439
2017
Q3
$3.88M Buy
116,050
+33,617
+41% +$1.16M ﹤0.01% 2263
2017
Q2
$2.93M Buy
+82,433
New +$2.78M ﹤0.01% 2415

Other funds holding QGEN

Ameriprise's QGEN Position: Q1 2026 in Review

Ameriprise reduced its Qiagen (QGEN) stake by 39% in Q1 2026, selling an estimated $260K and leaving 8,517 shares worth $341K. The position accounts for ﹤0.01% of the portfolio, ranked #3721.

Ameriprise first reported a position in QGEN in Q2 2017 and has held it in 30 quarters since. The position peaked at $6.42M in Q1 2020. 344 funds tracked by Wall St. Rank hold QGEN as of Q1 2026.

  • Ameriprise held 8,517 shares of Qiagen worth $341K as of Q1 2026.
  • Ameriprise sold 5,485 Qiagen shares in Q1 2026, an estimated $260K.
  • Qiagen made up ﹤0.01% of Ameriprise's portfolio in Q1 2026, its #3721 holding.
  • Ameriprise first reported a position in Qiagen in Q2 2017 and has held it in 30 quarters since.
  • Ameriprise's Qiagen position peaked at $6.42M in Q1 2020.
  • 344 funds tracked by Wall St. Rank held Qiagen as of Q1 2026.

Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.